This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n15http://localhost/temp/predkladatel/
n18http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n11http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F44555601%3A13510%2F14%3A43885799%21RIV15-MSM-13510___/
n16http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n6http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F44555601%3A13510%2F14%3A43885799%21RIV15-MSM-13510___
rdf:type
skos:Concept n16:Vysledek
dcterms:description
The objective of the article is to objectivise and assess the costs for the lung cancer therapy from the payer's (health insurance company) and the healthcare provider?s (hospital) perspective based on information available from several large hospitals and specialised centres. No comprehensive assessment of costs related to the treatment of lung cancers at all stages has been published in the Czech Republic to-date. The results in this study are calculated based on diagnostic and therapeutic algorithms, i.e. process maps. These, in turn, are derived from the recommended therapeutic procedures issued by the Masaryk Institute of Oncology, the University Hospital in Hradec Králové and the University Hospital in Plzeň. In total, the costs and reimbursements were calculated for 32 utilized algorithms, i.e. process maps. The costs for therapeutic processes account for 22 results, while 10 results correspond to diagnostic processes. Both direct and indirect costs were included in individual calculations. The calculations imply that treatment costs significantly differ depending on the selected diagnostic and therapeutic procedure. It becomes apparent that the setting of the reimbursement system presently generates different stimuli for providers, who may reach both positive and negative balances. This fact, in turn, may have an effect on the economic result leading, in its consequence, to the preference of more suitable alternatives in terms of reimbursement regardless of the optimum procedures for the particular patient. This fact is, to a certain extent, reflected by the reimbursements calculated by means of the DRG system. The given algorithms may potentially be used by health care providers to reach working costs, which will allow accurate calculations for particular hospitals The objective of the article is to objectivise and assess the costs for the lung cancer therapy from the payer's (health insurance company) and the healthcare provider?s (hospital) perspective based on information available from several large hospitals and specialised centres. No comprehensive assessment of costs related to the treatment of lung cancers at all stages has been published in the Czech Republic to-date. The results in this study are calculated based on diagnostic and therapeutic algorithms, i.e. process maps. These, in turn, are derived from the recommended therapeutic procedures issued by the Masaryk Institute of Oncology, the University Hospital in Hradec Králové and the University Hospital in Plzeň. In total, the costs and reimbursements were calculated for 32 utilized algorithms, i.e. process maps. The costs for therapeutic processes account for 22 results, while 10 results correspond to diagnostic processes. Both direct and indirect costs were included in individual calculations. The calculations imply that treatment costs significantly differ depending on the selected diagnostic and therapeutic procedure. It becomes apparent that the setting of the reimbursement system presently generates different stimuli for providers, who may reach both positive and negative balances. This fact, in turn, may have an effect on the economic result leading, in its consequence, to the preference of more suitable alternatives in terms of reimbursement regardless of the optimum procedures for the particular patient. This fact is, to a certain extent, reflected by the reimbursements calculated by means of the DRG system. The given algorithms may potentially be used by health care providers to reach working costs, which will allow accurate calculations for particular hospitals
dcterms:title
The Costs and Reimbursements for Lung Cancer Treatment Among Selected Health Care Providers in the Czech Republic The Costs and Reimbursements for Lung Cancer Treatment Among Selected Health Care Providers in the Czech Republic
skos:prefLabel
The Costs and Reimbursements for Lung Cancer Treatment Among Selected Health Care Providers in the Czech Republic The Costs and Reimbursements for Lung Cancer Treatment Among Selected Health Care Providers in the Czech Republic
skos:notation
RIV/44555601:13510/14:43885799!RIV15-MSM-13510___
n3:aktivita
n13:I
n3:aktivity
I
n3:cisloPeriodika
3
n3:dodaniDat
n9:2015
n3:domaciTvurceVysledku
n18:4996453
n3:druhVysledku
n14:J
n3:duvernostUdaju
n17:S
n3:entitaPredkladatele
n11:predkladatel
n3:idSjednocenehoVysledku
9077
n3:idVysledku
RIV/44555601:13510/14:43885799
n3:jazykVysledku
n12:eng
n3:klicovaSlova
health care reimbursement; process maps; healthcare costs; lung cancer
n3:klicoveSlovo
n5:process%20maps n5:lung%20cancer n5:health%20care%20reimbursement n5:healthcare%20costs
n3:kodStatuVydavatele
CZ - Česká republika
n3:kontrolniKodProRIV
[71D3488E5399]
n3:nazevZdroje
E+M. Ekonomie a Management
n3:obor
n10:AE
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
4
n3:rokUplatneniVysledku
n9:2014
n3:svazekPeriodika
17
n3:tvurceVysledku
Rogalewicz, Vladimír Šimrová, Jana Barták, Miroslav Vojtíšek, Radovan
n3:wos
000342261200007
s:issn
1212-3609
s:numberOfPages
12
n6:doi
10.15240/tul/001/2014-3-007
n15:organizacniJednotka
13510